London based health tech startup secures $11m investment
A UK and US health tech startup has announced that it has secured $11m of funding.
Quit Genius, which has its UK headquarters in London, has received the investment from a Series A funding round led by Octopus Ventures.
Hubert Burda Media’s international growth capital arm BurdaPrincipal Investments joined the round along with Y Combinator, Startup Health, and Triple Point Ventures.
The company uses cognitive behavioural therapy aims to aid users in quitting smoking and vaping tobacco products.
Quit Genius is expected to use the funding to expand into other types of addiction, including alcohol and opioid addiction.
Amelia Townsend, principal at BurdaPrincipal Investments, commented: “At BPI we are working in-depth into the health tech space.
“We are delighted to join the Quit Genius team and our fellow investors and are looking forward to being part of the journey!”
Looking to promote your product/service to SME businesses in your region? Find out how Bdaily can help →
Enjoy the read? Get Bdaily delivered.
Sign up to receive our popular morning London email for free.
How businesses can reduce workplace safety risks with custom solutions
Tech firm unveils jobs plan after £530,000 backing
SMEs urged to think big at Newcastle event
B Corp is a commitment, not a one-time win
Government must get in gear on vehicle transition
A legacy in stone and spirit
Shaping the future: Your guide to planning reforms
The future direction of expert witness services
Getting people into gear for a workplace return
What to expect in the Spring Statement
Sunderland leading way in UK office supply market
Key construction developments in 2025